In a meta‐analysis, DCP was a useful predictive factor indicating a 5‐fold increased risk for recurrence after transplantation.37 These markers, such as AFP and DCP, may represent a way to further refine selection criteria for LT based on tumor biology. This evidence concerns the gene AFP and neoplasm.